Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Inhibition of Phagocytosis by Silibinin in Mouse Macrophages

Version 1 : Received: 11 July 2023 / Approved: 12 July 2023 / Online: 12 July 2023 (10:56:25 CEST)

How to cite: Sun, K.-H.; Lee, M.-Y.; Jeon, Y.-J. Inhibition of Phagocytosis by Silibinin in Mouse Macrophages. Preprints 2023, 2023070826. https://doi.org/10.20944/preprints202307.0826.v1 Sun, K.-H.; Lee, M.-Y.; Jeon, Y.-J. Inhibition of Phagocytosis by Silibinin in Mouse Macrophages. Preprints 2023, 2023070826. https://doi.org/10.20944/preprints202307.0826.v1

Abstract

This study investigated the effects of silibinin, derived from milk thistle (Silybum marianum), on lipopolysaccharide (LPS)-induced morphological changes in mouse macrophages. Silibinin was treated at various doses and time points to assess its effects on macrophage activation including morphological changes and phagocytosis. Silibinin effectively inhibited LPS-induced pseudopodia formation and size increase, while unstimulated cells remained round. Silibinin's impact on phagocytosis was dose- and time-dependent, showing a decrease. We explored its mechanism of action on kinases using a MAPK array. Among the three MAPK family members tested, silibinin had a limited effect on JNK and p38 but significantly inhibited ERK1/2 and related RSK1/2. Silibinin also inhibited MKK6, AKT3, MSK2, p70S6K, and GSK-3β. These findings highlight silibinin's potent inhibitory effects on phagocytosis and morphological changes in macrophages. We suggest its potential as an anti-inflammatory agent due to its ability to target key inflammatory pathways involving ERK1/2 and related kinases. Overall, this study demonstrates the promising therapeutic properties of silibinin in modulating macrophage function and inflammation.

Keywords

macrophages; phagocytosis; silibinin; lamellipodia; filopodia

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.